RR Nadendla, J Satynarayana… - Journal of Pharmaceutical …, 2022 - academia.edu
Rivaroxaban (RN) is a recently developed potent oral anticoagulant. The aim of the present
study envisages compatibility studies of rivaroxaban with crospovidone, sodium startch …